Biome Australia Ltd · ASX:BIO
Biome Australia — Investor Presentation (August 2024)
37 slides from Biome Australia's investor presentation, Aug 26, 2024
Slide 1: Company Presentation
Biome Australia Limited | August 2024 Company Presentation Blair Norfolk, CEO & Managing Director
Slide 2: Disclaimer
Biome Australia Disclaimer This presentation and the information contained within it (the Past performance information included in this presentation is The recipient must, and agrees with the Company that it will, “information”) has been prepared solely for the use and benefit provided for illustrati
Slide 3: Our mission
Biome Australia Our mission To prevent disease, improve health outcomes and quality of life, and make our products accessible to all Company Presentation | August 2024 3
Slide 4: About Biome Australia
Biome Australia About Biome Australia Biome Australia (ASX: BIO) is focused on becoming a global leader in the complementary medicine industry, offering clinically-proven condition-specific probiotic products fueled by novel clinical research programs to cement and extend the evidence base of its prob
Slide 5: Biome Australia Company Presentation | August 2024
Biome Australia Company Presentation | August 2024 5
Slide 6: 01. Investment and Business Highlights
Biome Australia 01. Investment and Business Highlights Company Presentation | August 2024 6
Slide 7: Biome Business Opportunity
Biome Australia Biome Business Novel range of Live Biotherapeutics with co-prescribing medication opportunity Opportunity Landmark IP Deal executed on novel probiotic strains Three ongoing clinical trials on key products, see slide 21 International Expansion — UK, Irish health retail market launch t
Slide 8: Biome Business Opportunity
Biome Australia Biome Business Over 5,000 distribution points (Aus) following successful launch with Priceline Pharmacy Opportunity Average shopper — 2.1 units per transaction and 6 visits per year in pharmacy (Terry White Scan data) #1 growth Practitioner-Only brand in Australian Healthcare Practit
Slide 9: Financial Highlights
Biome Australia Financial Highlights Financial performance FY24 sales revenue $13.01m ‒ up 80% (vs pcp) $2.87m cash balance at June 30 2024 International Sales $894k - up 95% (vs pcp) FY24 NPAT($1,670,202) 45% improvement vs PCP Q4 FY24 sales revenue $3.81m ‒ up 88% vs PCP FY24 same-stores pharmacy
Slide 10: Growth Strategy
Biome Australia ‒ Increase Distribution in Pharmacy banner groups, HCPs and Medical Specialists ‒ Improve average sell through, same store sales and Increase product range. Grow Revenue ‒ Sales revenue increased: $832k (FY21) to $13m (FY24); equivalent to 4-Year CAGR of 97% ‒ Co-Prescribing with med
Slide 11: Half-Yearly Key Financial data points
Biome Australia Half-Yearly— Key Financial data points Revenue Gross Profit EBITDA (excl Share based payments) Company Presentation | August 2024 11
Slide 12: Annual Sales Revenue
Biome Australia Annual Sales Revenue Company Presentation | August 2024 12
Slide 13: 02. Activated Probiotics Range
Biome Australia 02. Activated Probiotics Range Company Presentation | August 2024 13
Slide 14: Activated Probiotics
Biome Australia Activated Probiotics Practitioners & Pharmacies CONSUMER BENEFITS 5x more effective delivery — MicrobacTM technology Shelf-stable Clinically documented probiotic strains Company Presentation | August 2024 14
Slide 15: 04. Distribution Network and Sales Model
Biome Australia 04. Distribution Network and Sales Model Company Presentation | August 2024 15
Slide 16: Australian Distribution Network
Biome Australia Australian Distribution Network Biome Australia currently has over 5000 distribution 5000+ Distribution points, between community pharmacies and Points independent health practitioners TerryWhite Chemmart—Activated Probiotics #1 growth brand in professional vitamin category Priceline
Slide 17: Pharmacy Core Ranges Authorised Distribution Partners
Biome Australia Pharmacy Core Ranges Authorised Distribution Partners Company Presentation | August 2024 17
Slide 18: Training and Education Driven Sales Model - Practitioner Only
Biome Australia Training and Education Driven Sales Model - Practitioner Only Unique Education and Service Model Drives Sales in Australia, UK and NZ Education and Service Support • The Biome sales team is a mix of health qualified practitioner education consultants and territory managers • Practiti
Slide 19: 03. Clinical Research
Biome Australia 03. Clinical Research Company Presentation | August 2024 19
Slide 20: Clinical pipeline - Indication overview
Biome Australia Clinical pipeline— ● Three ongoing clinical trials and further research Indication overview opportunities in discussion BIOME LIFT BIOME KIDS BIOME OSTEO Assessing the efficacy of the Biome Lift™ Analysing the influence of probiotic use on Examining the effect of 12-month Probiotic compa
Slide 21: Eczema Probiotic - Patient Results
Biome Australia Biome Eczema Probiotic - Patient Results “Jude and his mum has said thank you so much. They had tried every skin cream/soap/tablet and nothing has worked up until now. If you recall, Jude told one of the boys at school who asked what was wrong with his skin that he didn’t need to wor
Slide 22: Eczema Probiotic - Patient Results
Biome Australia Biome Eczema Probiotic - Patient Results Company Presentation | August 2024 22
Slide 23: Eczema - Patient Results
Biome Australia Biome Eczema - Patient Results Company Presentation | August 2024 23
Slide 24: Acne - Patient Results
Biome Australia Biome Acne - Patient Results I've been using the Biome Acne probiotic on my 12 year old for the mix of acne and peri-oral dermatitis he had going on. We saw great results in the first month and the bottom photo is after 2 months treatment. Company Presentation | August 2024 24
Slide 25: 05. International Markets
Biome Australia 05. International Markets Company Presentation | August 2024 25
Slide 26: United Kingdom & EU New Growth Markets
Biome Australia United Kingdom & EU New Growth Markets International markets grow 95% to reach ~$895k in sales revenue for FY24 UK & Ireland PRACTITIONER ● Strong foundation business ● Key driver of brand trust ● Supporting push into health retail PHARMACY & HEALTH FOOD ● New Channel launched in Q3
Slide 27: 06. New Product Development
Biome Australia 06. New Product Development Company Presentation | August 2024 27
Slide 28: Cholesterol Probiotic
Biome Australia Biome Cholesterol™ Probiotic To help support healthy cholesterol levels in healthy adults Clinically trialled formulation Guaranteed potency Launched 16 August 2024 Formulation Lactobacillus plantarum KABP™ 011 (CECT 7527) 0.4 BLB* Lactobacillus plantarum KABP™ 012 (CECT 7528) 0.4 BL
Slide 29: Key product research
Biome Australia Biome Cholesterol™ Probiotic Key product research In this double-blind, placebo-controlled, randomised trial, 60 patients with high cholesterol were treated with either with the combination of probiotic strains in Biome Cholesterol™ Probiotic or placebo once daily for 12 wks After 12
Slide 30: Key product research
Biome Australia Biome Cholesterol™ Probiotic Key product research In an observational study involving 343 patients, the probiotic was administered alone (n=185) or in combination with existing statin therapy (n=158). ● LDL was reduced by approximately 25% in the statin + probiotic group (p<0.001). ●
Slide 31: Adjunct prescribing Opportunities
Biome Australia Biome Cholesterol™ Probiotic Prescription medication Volume of prescriptions Action (rank in top 50 PBS drugs) from 2022-2023 Adjunct Rosuvastatin (#1) 16,469,144 Statin prescribing Atorvastatin (#2) 12,112,443 Statin Opportunities Simvastatin (#17) 1,941,055 Statin (top 50 PBS drugs
Slide 32: 07. Marketing
Biome Australia 07. Marketing Company Presentation | August 2024 32
Slide 33: Public Health Campaign
Biome Australia Public Health Campaign Final reach: 2.5 million Australians Results by platform TVC: 950,000 Transport panels: 495,000 Street posters: 405,000 Meta campaigns: ~375,000 YouTube campaign: 247,000 Landing page quiz: 500+ submissions, 63% completion rate Company Presentation | August 202
Slide 34: Pharmacy Advertising
Biome Australia Pharmacy Advertising Did you know a targeted Email banner probiotic can increase iron absorption? That’s right — there Print is a probiotic to improve iron absorption, providing a gentle approach to iron support… EDM Radio ad ft. Biome Iron Brand page Social content Company Presentat
Slide 35: Summary
Biome Australia Summary ● FY24 Sales Revenue $13.01m, up 80% ● FY24 pharmacy same stores sales up 75% (vs PCP) ● International sales reached $894k, up 95% ● Three ongoing clinical trials on key products, ● NPAT ($1,670,202), 45% improvement (vs PCP) see slide 21 ● Average shopper - 2.1 units per tra
Slide 36: Corporate Summary
Biome Australia Corporate Directors: 1) Mr Ilario Faenza (Chairman) Summary 2) 3) Ms Dominique Fisher AM Blair Vega Norfolk (Managing Director) ASX Code: BIO Current Assets (30 June 24) Listed Date: 30 November 2021 Cash at Bank $2,868,516 Accounts Receivables $2,870,022 Amount raised at IPO: $8m @
Slide 37: Contact details
Biome Australia Contact details: Blair Norfolk, CEO Douglas Loh, CFO e: corporate@biomeaustralia.com Websites: biomeaustralia.com activatedprobiotics.com.au Company Presentation | August 2024
Biome Australia — Investor Presentation (August 2024) on 6ix